The American Pharmacy Cooperative penned a letter to the Federal Trade Commission and Justice Department June 30, urging the agencies to stop Prime Therapeutics’ proposal to acquire Magellan, its rival pharmacy benefit manager, because the deal would reduce competition amid an already murky business.
Read the full post on Becker's Hospital Review - Healthcare News
